openPR Logo
Press release

Gel Permeation Chromatography (GPC) Market

07-05-2017 04:33 PM CET | Health & Medicine

Press release from: Clinical Diagnostic Report By CMI

Gel permeation chromatography (GPC) or size exclusion chromatography is a kind of liquid chromatography technique that separates analytes based on their size. This chromatography technique employs a stagnant liquid as the stationary phase that is present in the pores of beads and a flowing liquid as the mobile phase. Historically, the porous medium used in GPC was composed of a gel. Hence, the term gel permeation chromatography (GPC). Since, GPC is convenient, reproducible, simple, rapid, and reliable, it is expected to be generally applicable in various biochemical as well as clinical research. Currently, the market for gel permeation chromatography is expected to grow significantly due to the exponentially growing biotechnology and pharmaceutical industry along with increasing application of chromatographic technologies in various sectors of the healthcare industry.

The major types of gel permeation chromatography are as follows:

Conventional gel permeation chromatography
Multi-detector gel permeation chromatography
Based on components, the global gel permeation chromatography market is classified as follows:

Data processing equipment
Increasing Research Activities in Asia Pacific Region to Fuel the Demand for Gel Permeation Chromatography

Request a sample copy of this report@

In terms of regional distribution, use of gel permeation chromatography market is high in North America and Europe due to increasing number of ongoing research initiatives and domicile preference of this market for launching new technology. Asia Pacific, Latin America and Middle East, on the other hand, are expected to be the potential markets in the near future. Increasing number pharmaceutical companies and biologics manufacturers along with high adoption rate of advanced technological platforms and exponentially growing healthcare industry in these regions is expected to propel demand for gel chromatography in the near future.

The Gel Permeation Chromatography Market Dynamics

Globally, the gel permeation chromatography market is witnessing a substantial development. Increasing incidence rate of chronic disorders such as cancer and other human genetic disorders that requires sophisticated technologies for purification and analysis of nucleic acids as well as proteins are expected to boost the growth of the gel permeation chromatography market in the near future. Furthermore, other factors such as high demand for improved therapeutics and personalized treatment plans for various disease indications are driving the growth of this market.

Besides, increasing usage of sophisticated chromatographic techniques in the field of pharmaceutical and biotechnology industries along with incessant increase in novel product launches are further augmenting the growth prospects of this market. For instance, in January 2015, the U.K. based Malvern Instruments Ltd., launched a new fully integrated multi-detector gel permeation chromatography/size exclusion chromatography (GPC/SEC) platform, OMNISEC for delivering high performance and high productivity in various analytical laboratories. Hence, anticipated technological breakthroughs along with increasing number of research activities might drive the growth of the gel permeation chromatography market. However, high price of these chromatographic platforms and lack of skilled technician are some of the factors that might negatively influence the growth of the gel permeation chromatography market in the near future.

Fragmented Market to provide Opportunities for Small Players

Presently, the global gel permeation chromatography market is highly fragmented and competitive owing to the presence of many established players in the market. The market is expected to witness a significantly high growth due to increasing applications of metabolomics, proteomics and genomics in the field medicine and overall healthcare industry. Major companies operating in the field of gel permeation chromatography market are Agilent Technologies, GE Healthcare, Malvern Instruments Ltd., Shimadzu Corporation and Waters Corporation, amongst others.

Get More Details about this Report@

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Tel: +1-206-701-6702
Visit Coherent Market Insights Blog @
Connect with us on LinkedIn @

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gel Permeation Chromatography (GPC) Market here

News-ID: 609323 • Views: 399

More Releases from Clinical Diagnostic Report By CMI

Sepsis Diagnostic Market-Global Industry Insights, Trends, Outlook
Sepsis is life threatening complication caused due to the infection, which can result into organ failure, tissue damage, and ultimately lead to death if left untreated. If sepsis progresses to septic shock, it cause sudden drop in blood pressure and may leads to death of patient. Sepsis occurs due the infection in any part of the body. However the most common site of infections leading to the sepsis are lungs,
Liquid Biopsy Market - Insights
Liquid biopsy involves testing of the blood to identify biomarkers or cancer cells in the form of cells or pieces of DNA which are separated from the tumor and are circulating in the blood. Liquid biopsy helps in early detection of cancer, which would aid in adopting an optimal treatment plan. It is a non-invasive technique, which makes frequent testing possible, and effectiveness of cancer treatment can also be validated
Enteric Disease Testing Market - Global Industry Insights 2025
Enteric infection is a type of intestinal disease that causes symptoms ranging from mild gastroenteritis to systemic infections and severe diarrhea. According to WHO in 2017, Infectious gastroenteritis accounts for 1 billion cases of diarrhea globally and over 2 million deaths annually. In addition to this, according to Bill and Melinda Gates Foundation, 2017, enteric and diarrheal diseases leads to death of about 500,000 children, under the age of five
Hospital Acquired Disease Testing Market to Surpass US$ 2.7 Billion by 2025 Glob …
Hospital acquired Disease Testing – Hospital or Mortuary Hospital acquired disease or nosocomial infection is a localized or systemic condition in patients occurred due to adverse reaction caused by infectious toxin agents under medical care and were absent at the time of admission. Hospitals acquired infections results in prolonged hospital stay, antimicrobial resistance, long-term disabilities, and increase mortality rate. Pathogens responsible for nosocomial infections include viruses, fungal parasites, and bacteria. Hospital acquired

All 22 Releases